ES2173586T3 - Derivados de ciclohexandiol. - Google Patents

Derivados de ciclohexandiol.

Info

Publication number
ES2173586T3
ES2173586T3 ES98924303T ES98924303T ES2173586T3 ES 2173586 T3 ES2173586 T3 ES 2173586T3 ES 98924303 T ES98924303 T ES 98924303T ES 98924303 T ES98924303 T ES 98924303T ES 2173586 T3 ES2173586 T3 ES 2173586T3
Authority
ES
Spain
Prior art keywords
ciclohexandiol
derivatives
formula
eniliden
dodec
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98924303T
Other languages
English (en)
Inventor
Franz Bauer
Lawrence F Courtney
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Basilea Pharmaceutica AG
Original Assignee
Basilea Pharmaceutica AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basilea Pharmaceutica AG filed Critical Basilea Pharmaceutica AG
Application granted granted Critical
Publication of ES2173586T3 publication Critical patent/ES2173586T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C35/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C35/02—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring monocyclic
    • C07C35/08—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring monocyclic containing a six-membered rings
    • C07C35/17—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring monocyclic containing a six-membered rings with unsaturation only outside the ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)

Abstract

El compuesto, (E) (1R,3R) 5 [(R) 11 hidroxi 7,11 dimetil dodec 2 eniliden] ciclohexan 1,3 diol de la fórmula I: **fórmula**
ES98924303T 1997-05-23 1998-05-12 Derivados de ciclohexandiol. Expired - Lifetime ES2173586T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97108355 1997-05-23

Publications (1)

Publication Number Publication Date
ES2173586T3 true ES2173586T3 (es) 2002-10-16

Family

ID=8226819

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98924303T Expired - Lifetime ES2173586T3 (es) 1997-05-23 1998-05-12 Derivados de ciclohexandiol.

Country Status (10)

Country Link
US (1) US5969190A (es)
EP (1) EP0983221B1 (es)
JP (1) JP3276375B2 (es)
AR (1) AR012852A1 (es)
AU (1) AU7653998A (es)
CA (1) CA2288629A1 (es)
DE (1) DE69804606T2 (es)
ES (1) ES2173586T3 (es)
WO (1) WO1998052894A1 (es)
ZA (1) ZA984176B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6184422B1 (en) * 1998-02-26 2001-02-06 Hoffman-La Roche Inc. Cyclohexanediol derivatives
WO2002042247A1 (en) * 2000-11-22 2002-05-30 F.Hoffmann-La Roche Ag Retiferol derivatives and their use in the treatment of skin diseases or conditions associated with photodamage
US6723755B2 (en) * 2002-06-12 2004-04-20 Piotr Chomczynski Method of treating rosacea
US7812057B2 (en) * 2004-08-25 2010-10-12 Molecular Research Center, Inc. Cosmetic compositions
WO2007028000A2 (en) * 2005-08-30 2007-03-08 Wisconsin Alumni Research Foundation Des-c,d analogs of 1alpha,25-dihydroxy-19-norvitamin d3
JP2011510088A (ja) * 2008-01-22 2011-03-31 ウイスコンシン アラムニ リサーチ ファンデーション １α，２５−ジヒドロキシ−１９−ノル−ビタミンＤ３化合物の１３，１３−ジメチル−ｄｅｓ−Ｃ，Ｄ類似体並びにその局所組成物剤形及びそれによる皮膚状態の治療方法
GB2515128B (en) 2013-06-10 2015-05-27 Givaudan Sa Improvements in or relating to organic compounds
GB201421855D0 (en) 2014-12-09 2015-01-21 Givaudan Sa Improvements in or relating to organic compounds

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5225579A (en) * 1988-03-16 1993-07-06 Hoxan Corporation Method of manufacturing vitamin D2, Vitamin D3, activated type vitamin D2, activated type vitamin D3, and their derivatives
NZ232734A (en) * 1989-03-09 1991-11-26 Wisconsin Alumni Res Found 19-nor vitamin d derivatives and pharmaceutical compositions
AU650751B2 (en) * 1991-05-28 1994-06-30 Wisconsin Alumni Research Foundation Novel synthesis of 19-nor vitamin D compounds
CA2166898C (en) * 1993-07-09 2004-09-07 Roger Bouillon Novel structural analogues of vitamin d
PL174912B1 (pl) * 1994-01-24 1998-10-30 Inst Farmaceutyczny Nowe związki farmakologicznie czynne z grupy witamin D i sposób ich otrzymywania
AU4235696A (en) * 1994-11-21 1996-06-17 Wisconsin Alumni Research Foundation 18,19-dinor-vitamin d compounds

Also Published As

Publication number Publication date
JP2000512315A (ja) 2000-09-19
JP3276375B2 (ja) 2002-04-22
US5969190A (en) 1999-10-19
ZA984176B (en) 1999-01-08
WO1998052894A1 (en) 1998-11-26
EP0983221A1 (en) 2000-03-08
DE69804606D1 (en) 2002-05-08
EP0983221B1 (en) 2002-04-03
DE69804606T2 (de) 2002-11-07
CA2288629A1 (en) 1998-11-26
AR012852A1 (es) 2000-11-22
AU7653998A (en) 1998-12-11

Similar Documents

Publication Publication Date Title
ES2195970T3 (es) L-ribavirina y usos de la misma.
NL1002835A1 (nl) Synergistisch stabilisatormengsel.
DK0582829T3 (da) 9-(Substitueret glycyl)amido-6-demethyl-6-deoxytetracycliner som antibiotiske midler
DE69433784D1 (de) 9-(Substituiertes Glycyl)amido-6-(substituiert)-5-hydroxy-6-deoxytetracycline
ES2138691T3 (es) Procedimiento para la obtencion de derivados de n-acil-5-fluorocitidina.
HRP20030383B1 (en) Lactam compound
ES2187660T3 (es) Derivados de rapamicina.
AU1642795A (en) Substituted pyridylpyrazoles
HN1998000036A (es) Compuesto de pirazina
PT960107E (pt) Compostos de paclitaxel 6-tio-substituidos
EP1193270A3 (en) Pyrrolobenzodiazepines
AU5485698A (en) Oxyiminopregnancarbolactone
DK0750631T3 (da) Mercaptoacetylamido-1,3,4,5-tetrahydrobenzo[c]azepin-3-ondisulfidderivater som enkephalinase- og ACE-inhibitorer
ES2106700T3 (es) Procedimiento para la preparacion de derivados de la 4a,5,9,10,11,12-hexahidro-6h-benzofuro(3a,3,2-ef)(2)benzacepinas.
DK0869949T3 (da) Benzoxaziner som antimikrobielle midler
BR0008689A (pt) Composição antioxidante
SV1999000060A (es) Procedimiento para la preparacion de (s,s)-bencil-2,8-diazabiciclo 4.3.0 nonano ref. 32965-sv
ES2173586T3 (es) Derivados de ciclohexandiol.
CA2362698A1 (en) Resorcinol derivatives
BR9915692A (pt) Monohidrato de bromidrato de eletriptano
AU2881399A (en) N1-modified glycopeptides
BR0115139A (pt) Compostos bis-heterocìclicos com atividade antitumor e quimiossensibilizante
EP1008345A4 (en) ANTI-ALLERGIC AGENTS
BR9713176A (pt) Benzotiofenos amorfos,métodos de preparação e métodos de uso
BR9807785A (pt) Processo para a preparação do composto, e, composto

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 983221

Country of ref document: ES